{"id":2240,"date":"2025-02-04T09:57:05","date_gmt":"2025-02-04T09:57:05","guid":{"rendered":"https:\/\/www.cansativa.de\/?p=2240"},"modified":"2025-02-04T09:57:05","modified_gmt":"2025-02-04T09:57:05","slug":"cannabis-research-projects-driving-evidence-based-cannabis-regulation-in-germany-2","status":"publish","type":"post","link":"https:\/\/www.cansativa.de\/en\/2025\/02\/04\/cannabis-research-projects-driving-evidence-based-cannabis-regulation-in-germany-2\/","title":{"rendered":"Telemedicine and Medical Cannabis \u2013 Progress or Risk?"},"content":{"rendered":"

[vc_row row_height_percent=”0″ override_padding=”yes” h_padding=”3″ top_padding=”3″ bottom_padding=”3″ overlay_alpha=”50″ gutter_size=”6″ column_width_percent=”100″ shift_y=”0″ z_index=”0″ uncode_shortcode_id=”166943″][vc_column width=”2\/3″][vc_column_text uncode_shortcode_id=”174408″]Telemedicine: An Opportunity or a Challenge? <\/strong><\/p>\n

While medical cannabis is becoming increasingly destigmatized, some telemedicine services have recently come under scrutiny. In particular, concerns have been raised about the practice of issuing prescriptions based solely on an online questionnaire without direct doctor-patient interaction, raising fears of misuse. However, it is important to recognize that telemedicine has become an integral part of healthcare in many areas, offering enormous benefits to countless patients.<\/p>\n

Telemedicine allows for quick and convenient medical consultations \u2014 especially in rural regions where specialist shortages are a pressing issue. For chronically ill patients who rely on continuous treatment, digital access to healthcare can be a major relief.<\/p>\n

At the same time, concerns about compliance with existing regulations and quality assurance are valid. However, rather than questioning telemedicine as a whole, the discussion should focus on how to ensure proper enforcement of existing rules to safeguard both patient protection and the integrity of medical care.<\/p>\n

A Balanced Perspective on the Debate <\/strong><\/p>\n

This debate highlights that a targeted regulatory response should not be limited to medical cannabis alone but should consider telemedicine as a healthcare model in general. There are already established legal frameworks, such as the EU Patient Mobility Directive and the Medicinal Products Advertising Act (Heilmittelwerbegesetz \u2013 HWG), which set standards for safe and regulated cross-border access to telemedical services.<\/p>\n

The concerns surrounding telemedicine demonstrate that new digital healthcare models are not inherently problematic but require clear guidelines to ensure safe and high-quality applications. Medical cannabis is not the only field where telemedical services are playing an increasingly important role\u2014this issue affects the entire healthcare sector.<\/p>\n

Regulate Telemedicine Sensibly, Not Demonize It <\/strong><\/p>\n

The political debate should focus on how telemedicine can be responsibly utilized rather than portraying it as a problem in itself.<\/p>\n

A rational, solution-oriented discussion is needed\u2014one that involves patients, doctors, and policymakers alike.<\/p>\n

Modern, digital healthcare solutions offer substantial benefits\u2014not just for medical cannabis but for numerous other prescription medications.<\/p>\n

The key challenge is to strengthen and enforce existing regulations while further developing policies that ensure quality and safety for all patients. [\/vc_column_text][vc_column_text uncode_shortcode_id=”150887″]Anything else?<\/strong><\/p>\n

Do you have specific questions or suggestions for the Cannabis Briefing? Then send us an email to\u00a0briefing@www.cansativa.de<\/a>. If you are interested in revolutionising the cannabis industry with us, then stay tuned and follow our briefings!<\/p>\n

We wish you a good read!<\/p>\n

Best wishes from both of us,<\/span>[\/vc_column_text][vc_row_inner limit_content=””][vc_column_inner width=”1\/2″][vc_single_image media=”742″ media_width_use_pixel=”yes” uncode_shortcode_id=”192986″ media_width_pixel=”100″][vc_custom_heading heading_semantic=”h3″ text_size=”h3″ uncode_shortcode_id=”933932″ subheading=”Founder & Managing Director Cansativa”]Jakob Sons[\/vc_custom_heading][\/vc_column_inner][vc_column_inner width=”1\/2″][vc_single_image media=”741″ media_width_use_pixel=”yes” uncode_shortcode_id=”178400″ media_width_pixel=”100″][vc_custom_heading heading_semantic=”h3″ text_size=”h3″ uncode_shortcode_id=”607403″ subheading=”Founder & Managing Director Cansativa”]Benedikt Sons[\/vc_custom_heading][\/vc_column_inner][\/vc_row_inner][\/vc_column][vc_column column_width_percent=”100″ gutter_size=”3″ back_color=”color-xsdn” overlay_alpha=”50″ shift_x=”0″ shift_y=”0″ shift_y_down=”0″ z_index=”0″ medium_width=”0″ mobile_width=”0″ sticky=”yes” radius=”std” shadow=”std” width=”1\/3″ uncode_shortcode_id=”109911″ back_color_type=”uncode-palette”][vc_row_inner limit_content=””][vc_column_inner width=”1\/2″][vc_single_image media=”744″ media_width_percent=”100″ uncode_shortcode_id=”159176″][\/vc_column_inner][vc_column_inner column_width_percent=”100″ position_vertical=”middle” gutter_size=”3″ overlay_alpha=”50″ shift_x=”0″ shift_y=”0″ shift_y_down=”0″ z_index=”0″ medium_width=”0″ mobile_width=”0″ width=”1\/2″ uncode_shortcode_id=”680020″][vc_single_image media=”742″ media_width_use_pixel=”yes” uncode_shortcode_id=”192986″ media_width_pixel=”100″][\/vc_column_inner][\/vc_row_inner][vc_custom_heading heading_semantic=”h3″ text_size=”h3″ uncode_shortcode_id=”850716″ subheading=”Founder & Managing Director Cansativa”]Jakob Sons[\/vc_custom_heading][vc_separator sep_color=”,Default”][vc_row_inner limit_content=””][vc_column_inner width=”1\/2″][vc_single_image media=”743″ media_width_percent=”100″ uncode_shortcode_id=”886589″][\/vc_column_inner][vc_column_inner column_width_percent=”100″ position_vertical=”middle” gutter_size=”3″ overlay_alpha=”50″ shift_x=”0″ shift_y=”0″ shift_y_down=”0″ z_index=”0″ medium_width=”0″ mobile_width=”0″ width=”1\/2″ uncode_shortcode_id=”680020″][vc_single_image media=”741″ media_width_use_pixel=”yes” uncode_shortcode_id=”178400″ media_width_pixel=”100″][\/vc_column_inner][\/vc_row_inner][vc_custom_heading heading_semantic=”h3″ text_size=”h3″ uncode_shortcode_id=”132885″ subheading=”Founder & Managing Director Cansativa”]Benedikt Sons[\/vc_custom_heading][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

A Step Forward: Easier Access to Medical Cannabis
\nSince the legal changes in spring 2024, medical cannabis can now be prescribed with significantly less bureaucratic effort \u2014 just like any other prescription medication. This reform was a crucial step in reducing administrative burdens for doctors and patients alike. At the same time, it marked a milestone for the acceptance of medical cannabis as an equal treatment option. <\/p>\n","protected":false},"author":5,"featured_media":1736,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[352],"tags":[],"class_list":["post-2240","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-briefing-en"],"yoast_head":"\nTelemedicine and Medical Cannabis \u2013 Progress or Risk? - Cansativa Group<\/title>\n<meta name=\"description\" content=\"Since 2024, medical cannabis prescriptions have become easier, but telemedicine is under scrutiny. Why a balanced regulatory approach is essential and what solutions exist\u2014find out in the latest Cannabis Briefing!\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cansativa.de\/en\/2025\/02\/04\/cannabis-research-projects-driving-evidence-based-cannabis-regulation-in-germany-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Telemedicine and Medical Cannabis \u2013 Progress or Risk? - Cansativa Group\" \/>\n<meta property=\"og:description\" content=\"Since 2024, medical cannabis prescriptions have become easier, but telemedicine is under scrutiny. Why a balanced regulatory approach is essential and what solutions exist\u2014find out in the latest Cannabis Briefing!\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cansativa.de\/en\/2025\/02\/04\/cannabis-research-projects-driving-evidence-based-cannabis-regulation-in-germany-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Cansativa Group\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-04T09:57:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cansativa.de\/wp-content\/uploads\/2024\/05\/CSTV-Thumbnail-Webseite.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Cansativa Admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Cansativa Admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.cansativa.de\\\/en\\\/2025\\\/02\\\/04\\\/cannabis-research-projects-driving-evidence-based-cannabis-regulation-in-germany-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cansativa.de\\\/en\\\/2025\\\/02\\\/04\\\/cannabis-research-projects-driving-evidence-based-cannabis-regulation-in-germany-2\\\/\"},\"author\":{\"name\":\"Cansativa Admin\",\"@id\":\"https:\\\/\\\/www.cansativa.de\\\/#\\\/schema\\\/person\\\/3ff696b2d8ec95893e32aa704f0006ca\"},\"headline\":\"Telemedicine and Medical Cannabis \u2013 Progress or Risk?\",\"datePublished\":\"2025-02-04T09:57:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.cansativa.de\\\/en\\\/2025\\\/02\\\/04\\\/cannabis-research-projects-driving-evidence-based-cannabis-regulation-in-germany-2\\\/\"},\"wordCount\":797,\"image\":{\"@id\":\"https:\\\/\\\/www.cansativa.de\\\/en\\\/2025\\\/02\\\/04\\\/cannabis-research-projects-driving-evidence-based-cannabis-regulation-in-germany-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.cansativa.de\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/CSTV-Thumbnail-Webseite.png\",\"articleSection\":[\"Briefing\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.cansativa.de\\\/en\\\/2025\\\/02\\\/04\\\/cannabis-research-projects-driving-evidence-based-cannabis-regulation-in-germany-2\\\/\",\"url\":\"https:\\\/\\\/www.cansativa.de\\\/en\\\/2025\\\/02\\\/04\\\/cannabis-research-projects-driving-evidence-based-cannabis-regulation-in-germany-2\\\/\",\"name\":\"Telemedicine and Medical Cannabis \u2013 Progress or Risk? - Cansativa Group\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cansativa.de\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.cansativa.de\\\/en\\\/2025\\\/02\\\/04\\\/cannabis-research-projects-driving-evidence-based-cannabis-regulation-in-germany-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cansativa.de\\\/en\\\/2025\\\/02\\\/04\\\/cannabis-research-projects-driving-evidence-based-cannabis-regulation-in-germany-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.cansativa.de\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/CSTV-Thumbnail-Webseite.png\",\"datePublished\":\"2025-02-04T09:57:05+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.cansativa.de\\\/#\\\/schema\\\/person\\\/3ff696b2d8ec95893e32aa704f0006ca\"},\"description\":\"Since 2024, medical cannabis prescriptions have become easier, but telemedicine is under scrutiny. Why a balanced regulatory approach is essential and what solutions exist\u2014find out in the latest Cannabis Briefing!\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.cansativa.de\\\/en\\\/2025\\\/02\\\/04\\\/cannabis-research-projects-driving-evidence-based-cannabis-regulation-in-germany-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.cansativa.de\\\/en\\\/2025\\\/02\\\/04\\\/cannabis-research-projects-driving-evidence-based-cannabis-regulation-in-germany-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.cansativa.de\\\/en\\\/2025\\\/02\\\/04\\\/cannabis-research-projects-driving-evidence-based-cannabis-regulation-in-germany-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.cansativa.de\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/CSTV-Thumbnail-Webseite.png\",\"contentUrl\":\"https:\\\/\\\/www.cansativa.de\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/CSTV-Thumbnail-Webseite.png\",\"width\":1080,\"height\":1080},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.cansativa.de\\\/en\\\/2025\\\/02\\\/04\\\/cannabis-research-projects-driving-evidence-based-cannabis-regulation-in-germany-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/www.cansativa.de\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Telemedicine and Medical Cannabis \u2013 Progress or Risk?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.cansativa.de\\\/#website\",\"url\":\"https:\\\/\\\/www.cansativa.de\\\/\",\"name\":\"Cansativa Group\",\"description\":\"We enable Cannabis\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.cansativa.de\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.cansativa.de\\\/#\\\/schema\\\/person\\\/3ff696b2d8ec95893e32aa704f0006ca\",\"name\":\"Cansativa Admin\",\"sameAs\":[\"https:\\\/\\\/www.cansativa.de\"],\"url\":\"https:\\\/\\\/www.cansativa.de\\\/en\\\/author\\\/alexander-kiefercansativa-de\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Telemedicine and Medical Cannabis \u2013 Progress or Risk? - Cansativa Group","description":"Since 2024, medical cannabis prescriptions have become easier, but telemedicine is under scrutiny. Why a balanced regulatory approach is essential and what solutions exist\u2014find out in the latest Cannabis Briefing!","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cansativa.de\/en\/2025\/02\/04\/cannabis-research-projects-driving-evidence-based-cannabis-regulation-in-germany-2\/","og_locale":"en_US","og_type":"article","og_title":"Telemedicine and Medical Cannabis \u2013 Progress or Risk? - Cansativa Group","og_description":"Since 2024, medical cannabis prescriptions have become easier, but telemedicine is under scrutiny. Why a balanced regulatory approach is essential and what solutions exist\u2014find out in the latest Cannabis Briefing!","og_url":"https:\/\/www.cansativa.de\/en\/2025\/02\/04\/cannabis-research-projects-driving-evidence-based-cannabis-regulation-in-germany-2\/","og_site_name":"Cansativa Group","article_published_time":"2025-02-04T09:57:05+00:00","og_image":[{"width":1080,"height":1080,"url":"https:\/\/www.cansativa.de\/wp-content\/uploads\/2024\/05\/CSTV-Thumbnail-Webseite.png","type":"image\/png"}],"author":"Cansativa Admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Cansativa Admin","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.cansativa.de\/en\/2025\/02\/04\/cannabis-research-projects-driving-evidence-based-cannabis-regulation-in-germany-2\/#article","isPartOf":{"@id":"https:\/\/www.cansativa.de\/en\/2025\/02\/04\/cannabis-research-projects-driving-evidence-based-cannabis-regulation-in-germany-2\/"},"author":{"name":"Cansativa Admin","@id":"https:\/\/www.cansativa.de\/#\/schema\/person\/3ff696b2d8ec95893e32aa704f0006ca"},"headline":"Telemedicine and Medical Cannabis \u2013 Progress or Risk?","datePublished":"2025-02-04T09:57:05+00:00","mainEntityOfPage":{"@id":"https:\/\/www.cansativa.de\/en\/2025\/02\/04\/cannabis-research-projects-driving-evidence-based-cannabis-regulation-in-germany-2\/"},"wordCount":797,"image":{"@id":"https:\/\/www.cansativa.de\/en\/2025\/02\/04\/cannabis-research-projects-driving-evidence-based-cannabis-regulation-in-germany-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cansativa.de\/wp-content\/uploads\/2024\/05\/CSTV-Thumbnail-Webseite.png","articleSection":["Briefing"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.cansativa.de\/en\/2025\/02\/04\/cannabis-research-projects-driving-evidence-based-cannabis-regulation-in-germany-2\/","url":"https:\/\/www.cansativa.de\/en\/2025\/02\/04\/cannabis-research-projects-driving-evidence-based-cannabis-regulation-in-germany-2\/","name":"Telemedicine and Medical Cannabis \u2013 Progress or Risk? - Cansativa Group","isPartOf":{"@id":"https:\/\/www.cansativa.de\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cansativa.de\/en\/2025\/02\/04\/cannabis-research-projects-driving-evidence-based-cannabis-regulation-in-germany-2\/#primaryimage"},"image":{"@id":"https:\/\/www.cansativa.de\/en\/2025\/02\/04\/cannabis-research-projects-driving-evidence-based-cannabis-regulation-in-germany-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cansativa.de\/wp-content\/uploads\/2024\/05\/CSTV-Thumbnail-Webseite.png","datePublished":"2025-02-04T09:57:05+00:00","author":{"@id":"https:\/\/www.cansativa.de\/#\/schema\/person\/3ff696b2d8ec95893e32aa704f0006ca"},"description":"Since 2024, medical cannabis prescriptions have become easier, but telemedicine is under scrutiny. Why a balanced regulatory approach is essential and what solutions exist\u2014find out in the latest Cannabis Briefing!","breadcrumb":{"@id":"https:\/\/www.cansativa.de\/en\/2025\/02\/04\/cannabis-research-projects-driving-evidence-based-cannabis-regulation-in-germany-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cansativa.de\/en\/2025\/02\/04\/cannabis-research-projects-driving-evidence-based-cannabis-regulation-in-germany-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.cansativa.de\/en\/2025\/02\/04\/cannabis-research-projects-driving-evidence-based-cannabis-regulation-in-germany-2\/#primaryimage","url":"https:\/\/www.cansativa.de\/wp-content\/uploads\/2024\/05\/CSTV-Thumbnail-Webseite.png","contentUrl":"https:\/\/www.cansativa.de\/wp-content\/uploads\/2024\/05\/CSTV-Thumbnail-Webseite.png","width":1080,"height":1080},{"@type":"BreadcrumbList","@id":"https:\/\/www.cansativa.de\/en\/2025\/02\/04\/cannabis-research-projects-driving-evidence-based-cannabis-regulation-in-germany-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/www.cansativa.de\/"},{"@type":"ListItem","position":2,"name":"Telemedicine and Medical Cannabis \u2013 Progress or Risk?"}]},{"@type":"WebSite","@id":"https:\/\/www.cansativa.de\/#website","url":"https:\/\/www.cansativa.de\/","name":"Cansativa Group","description":"We enable Cannabis","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cansativa.de\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.cansativa.de\/#\/schema\/person\/3ff696b2d8ec95893e32aa704f0006ca","name":"Cansativa Admin","sameAs":["https:\/\/www.cansativa.de"],"url":"https:\/\/www.cansativa.de\/en\/author\/alexander-kiefercansativa-de\/"}]}},"_links":{"self":[{"href":"https:\/\/www.cansativa.de\/en\/wp-json\/wp\/v2\/posts\/2240","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cansativa.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cansativa.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cansativa.de\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cansativa.de\/en\/wp-json\/wp\/v2\/comments?post=2240"}],"version-history":[{"count":1,"href":"https:\/\/www.cansativa.de\/en\/wp-json\/wp\/v2\/posts\/2240\/revisions"}],"predecessor-version":[{"id":2241,"href":"https:\/\/www.cansativa.de\/en\/wp-json\/wp\/v2\/posts\/2240\/revisions\/2241"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cansativa.de\/en\/wp-json\/wp\/v2\/media\/1736"}],"wp:attachment":[{"href":"https:\/\/www.cansativa.de\/en\/wp-json\/wp\/v2\/media?parent=2240"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cansativa.de\/en\/wp-json\/wp\/v2\/categories?post=2240"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cansativa.de\/en\/wp-json\/wp\/v2\/tags?post=2240"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}